Barry Alan Siegel
#127,757
Most Influential Person Now
Barry Alan Siegel's AcademicInfluence.com Rankings
Barry Alan Siegelmedical Degrees
Medical
#2060
World Rank
#2457
Historical Rank
Radiology
#38
World Rank
#48
Historical Rank
Barry Alan Siegelphilosophy Degrees
Philosophy
#6056
World Rank
#9023
Historical Rank
Logic
#3250
World Rank
#4378
Historical Rank
Download Badge
Medical Philosophy
Why Is Barry Alan Siegel Influential?
(Suggest an Edit or Addition)Barry Alan Siegel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. (2007) (1335)
- Recommendations on the Use of 18F-FDG PET in Oncology (2008) (766)
- Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. (2006) (711)
- Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. (2006) (686)
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development (2005) (632)
- Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET) (2004) (604)
- Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. (2004) (563)
- Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. (2001) (440)
- Breast cancer: PET imaging of estrogen receptors. (1988) (401)
- Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. (2001) (383)
- Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. (2008) (375)
- In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM (2003) (359)
- Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. (2003) (331)
- Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. (2004) (330)
- Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. (1995) (311)
- Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. (1997) (309)
- Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia (2019) (307)
- FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. (2000) (306)
- 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. (2003) (300)
- Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. (2003) (289)
- Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum (2000) (284)
- 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? (2006) (283)
- Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study. (2009) (281)
- The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival (2007) (278)
- Positron emission tomographic assessment of ”metabolic flare” to predict response of metastatic breast cancer to antiestrogen therapy (1999) (276)
- Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. (2007) (274)
- Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. (2010) (263)
- Improvement in staging of esophageal cancer with the addition of positron emission tomography. (1997) (262)
- Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. (1998) (248)
- Ventilation-perfusion studies in suspected pulmonary embolism. (1979) (247)
- Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. (2004) (243)
- Positron Tomographic Assessment of 16α-[18F] Fluoro-17β-Estradiol Uptake in Metastatic Breast Carcinoma (1991) (233)
- Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. (2004) (232)
- An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax (2013) (231)
- Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. (2003) (216)
- Positron tomographic assessment of androgen receptors in prostatic carcinoma (2005) (211)
- Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone) (2008) (210)
- Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. (2009) (209)
- Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. (1996) (204)
- Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry (2008) (202)
- Magnetic resonance imaging of the normal and ischemic femoral head. (1984) (195)
- PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer (2009) (193)
- Survival of Patients Evaluated by FDG-PET Before Hepatic Resection for Metastatic Colorectal Carcinoma: A Prospective Database Study (2001) (192)
- FDG-PET/CT in the evaluation of anal carcinoma. (2006) (181)
- Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma (2014) (181)
- Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. (2010) (181)
- 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer (2017) (180)
- Indium‐III: a New Radionuclide Label for Studying Human Platelet Kinetics (1979) (179)
- An Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine Cervix (2008) (172)
- Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography (1997) (170)
- Preoperative lymph node staging of early‐stage cervical carcinoma by [18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (2005) (169)
- Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. (2004) (169)
- Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. (1993) (168)
- Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. (2002) (161)
- Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial. (2013) (160)
- Tumor Hypoxia Detected by Positron Emission Tomography with 60Cu-ATSM as a Predictor of Response and Survival in Patients Undergoing Neoadjuvant Chemoradiotherapy for Rectal Carcinoma: A Pilot Study (2008) (160)
- 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation (2011) (155)
- Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. (2001) (149)
- Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. (1990) (146)
- PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. (1992) (144)
- Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. (1992) (143)
- Detection of Remote Myocardial Infarction in Patients with Positron Emission Transaxial Tomography and Intravenous “IC-Palmitate (1977) (142)
- The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. (2007) (141)
- Exploratory Study of 99mTc-EC20 Imaging for Identifying Patients with Folate Receptor–Positive Solid Tumors (2008) (140)
- Acute scrotal disorders: prospective comparison of color Doppler US and testicular scintigraphy. (1990) (139)
- Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. (1996) (139)
- 18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. (2007) (131)
- RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. (1995) (131)
- SNM Practice Guideline for Lung Scintigraphy 4.0* (2012) (129)
- Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non–Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort (2016) (128)
- Functional Response of the Right Ventricle to Myocardial Infarction: Dependence on the Site of Left Ventricular Infarction (1981) (127)
- Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. (2008) (124)
- Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. (2003) (123)
- Qualification of PET Scanners for Use in Multicenter Cancer Clinical Trials: The American College of Radiology Imaging Network Experience (2009) (121)
- Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. (1996) (120)
- NCCN task force: clinical utility of PET in a variety of tumor types. (2009) (119)
- X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. (1989) (117)
- SCINTIGRAPHIC DETECTION OF ATHEROSCLEROTIC LESIONS AND VENOUS THROMBI IN MAN BY INDIUM-111-LABELLED AUTOLOGOUS PLATELETS (1978) (117)
- Color Doppler US of the scrotum. (1991) (117)
- Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. (2006) (115)
- Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial. (2018) (114)
- Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma. (2000) (113)
- Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. (1992) (108)
- Procedure Guideline for SPECT/CT Imaging 1.0. (2006) (106)
- Brain metastases from non-central nervous system tumors: evaluation with PET. (1993) (106)
- A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. (2009) (105)
- The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial (2019) (105)
- F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. (2006) (105)
- Posttherapy surveillance monitoring of cervical cancer by FDG-PET. (2003) (104)
- Pelvic lymph node F‐18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer (2010) (102)
- Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. (2005) (101)
- Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. (2002) (100)
- Adult idiopathic communicating hydrocephalus with and without shunting. (1978) (100)
- FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. (2002) (99)
- Lymph node control in cervical cancer. (2004) (99)
- FDG-PET-based prognostic nomograms for locally advanced cervical cancer. (2012) (98)
- Prognostic Value of Preoperative Positron Emission Tomography in Resected Stage I Non-small Cell Lung Cancer (2008) (96)
- PET in breast cancer. (1998) (96)
- Carpal avascular necrosis: MR imaging. (1986) (95)
- The National Oncologic PET Registry (NOPR): Design and Analysis Plan (2007) (93)
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study (2021) (90)
- Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. (1987) (89)
- A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY) (2021) (89)
- Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. (1991) (89)
- Chemotherapy-Induced Normalization of FDG Uptake by Colorectal Liver Metastases Does Not Usually Indicate Complete Pathologic Response (2007) (89)
- Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. (2011) (88)
- Skeletal uptake of 99mTc-diphosphonate in relation to local bone blood flow. (1976) (88)
- Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials (2015) (88)
- Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. (2004) (87)
- Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. (2009) (87)
- Impact of 18F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry (2014) (87)
- Changes in cervical cancer FDG uptake during chemoradiation and association with response. (2013) (85)
- [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer (2016) (84)
- FDG-PET evaluation of vaginal carcinoma. (2005) (84)
- Scintigraphic Detection of Carotid Atherosclerosis with Indium‐111‐labeled Autologous Platelets (1980) (83)
- Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer. (2002) (83)
- 11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction (2013) (82)
- 18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry (2015) (81)
- Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix. (2003) (81)
- FDG-PET evaluation of indeterminate pancreatic masses. (1996) (80)
- Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. (2010) (80)
- Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas. (1991) (77)
- FDG-PET Evaluation of Carcinoma of the Cervix. (1999) (77)
- Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence. (2014) (75)
- Tc-99m-DTPA aerosol and radioactive gases compared as adjuncts to perfusion scintigraphy in patients with suspected pulmonary embolism. (1984) (73)
- Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease (1992) (72)
- Cervical cancer histology and tumor differentiation affect 18F‐fluorodeoxyglucose uptake (2009) (71)
- Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione (2012) (71)
- Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. (2002) (70)
- A new technique for the calculation of left ventricular ejection fraction. (1972) (70)
- Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. (1991) (70)
- Rapid onset Mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis (2003) (68)
- Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235 (2016) (68)
- Comparison of In-111-labeled platelets and iodinated fibrinogen for the detection of deep vein thrombosis. (1978) (67)
- The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development. (2007) (66)
- Whole-body MR imaging for staging of malignant tumors in pediatric patients: results of the American College of Radiology Imaging Network 6660 Trial. (2013) (65)
- 99mTc-pyrophosphate bone imaging in osteopoikilosis, osteopathia striata, and melorheostosis. (1978) (64)
- Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. (1992) (63)
- Gallium-68 labeled red cells and platelets: new agents for positron tomography. (1977) (63)
- Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235. (2015) (61)
- Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors. (1996) (59)
- Experimental cerebral microembolism. Multiple tracer assessment of brain edema. (1972) (59)
- 16 alpha-[77Br]bromoestradiol: dosimetry and preliminary clinical studies. (1982) (58)
- Scintigraphic detection of pulmonary embolism in patients with obstructive pulmonary disease. (1981) (58)
- 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer. (2008) (57)
- Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis. (2010) (56)
- Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? (2011) (54)
- Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation. (2004) (53)
- Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial (2017) (53)
- Interpretation of indeterminate lung scintigrams. (1979) (52)
- Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer. (2019) (52)
- Neoplasms of the esophagus and stomach. (2004) (51)
- Ibrutinib Monotherapy in Relapsed/Refractory Follicular Lymphoma (FL): Preliminary Results of a Phase 2 Consortium (P2C) Trial (2014) (50)
- Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study (2018) (50)
- Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma (2012) (50)
- Mosaic oligemia simulating pulmonary infiltrates on CT. (1986) (50)
- Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer (2017) (50)
- Aspirin inhibition of platelet deposition at angioplasty sites: demonstration by platelet scintigraphy. (1984) (50)
- Combined [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Detection of Recurrent, 131I-Negative Thyroid Cancer (2007) (49)
- ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression (2012) (49)
- Surveillance of patients to detect recurrent thyroid carcinoma (1999) (48)
- Tumor volume and subvolume concordance between FDG‐PET/CT and diffusion‐weighted MRI for squamous cell carcinoma of the cervix (2013) (47)
- Procedure guideline for tumor imaging with F-18 FDG PET/CT (2006) (46)
- Enlarged cerebrospinal fluid spaces in infants with subdural hematomas. (1982) (45)
- Combined PET/MR: Where Are We Now? Summary Report of the Second International Workshop on PET/MR Imaging April 8–12, 2013, Tubingen, Germany (2014) (45)
- Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry (2014) (45)
- Indium‐111 platelet scintigraphy in cerebrovascular disease (1982) (45)
- Localization of technetium‐99m diphosphonate in acutely injured muscle (1977) (44)
- "Low-probability" ventilation-perfusion scintigrams: clinical outcomes in 99 patients. (1985) (44)
- Effect of irradiation on tumor microvascular permeability to macromolecules (1972) (44)
- FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival. (2020) (43)
- Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer (2017) (43)
- Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement? (2012) (43)
- Scintigraphic diagnosis of experimental pulmonary embolism with In-111-labeled platelets. (1977) (42)
- Evaluation of myocardial metabolism and perfusion with positron-emitting radionuclides. (1977) (42)
- Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer (2018) (41)
- The Future of Nuclear Medicine, Molecular Imaging, and Theranostics. (2020) (41)
- Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. (2005) (41)
- Scintigraphy with 111In-labeled autologous platelets in venous thromboembolism. (1980) (41)
- Prognostic Value of Fluorodeoxyglucose Positron Emission Tomography in Non-small Cell Lung Cancer: A Review (2006) (41)
- Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. (1995) (40)
- Computed tomography and radionuclide imaging of the liver: a comparative evaluation. (1978) (40)
- Phase 1 Evaluation of [64Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors (2016) (39)
- A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. (2008) (39)
- A phase 2 trial of induction nab‐paclitaxel and cetuximab given with cisplatin and 5‐fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck (2013) (39)
- Osteomyelitis and infarction in sickle cell hemoglobinopathies: differentiation by combined technetium and gallium scintigraphy. (1984) (38)
- Impact of 18F-FDG PET Used After Initial Treatment of Cancer: Comparison of the National Oncologic PET Registry 2006 and 2009 Cohorts (2012) (38)
- Abnormal technetium-99m pyrophosphate images in unstable angina: ischemia versus infarction? (1979) (37)
- Chemical and biologic properties of isolated radiolabeled bleomycin preparations. (1975) (37)
- PET and PET/CT Reports: Observations from the National Oncologic PET Registry (2010) (36)
- Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment. (2020) (36)
- [(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection. (2016) (36)
- Scintigraphic detection of platelet deposition in atherosclerotic macaques: a new technique for investigation of antithrombotic drugs. (1982) (36)
- The Lack of Evidence for PET or PET/CT Surveillance of Patients with Treated Lymphoma, Colorectal Cancer, and Head and Neck Cancer: A Systematic Review (2013) (35)
- Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. (2007) (34)
- 99mTc‐diphosphonate uptake in skeletal muscle (1975) (34)
- Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1. (1998) (34)
- Oncologic PET/CT: current status and controversies (2005) (33)
- Elimination of contaminant Kryptofix 2.2.2 in the routine production of 2-[18F]fluoro-2-deoxy-D-glucose. (1989) (33)
- Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235 (2016) (33)
- Relative accuracy of two diagnostic schemes for detection of pulmonary embolism by ventilation-perfusion scintigraphy. (1982) (33)
- The use of nuclear medicine in the diagnosis of lung disease. (1973) (32)
- Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial (2016) (32)
- Steroid therapy of brain edema. Ineffectiveness in experimental cerebral microembolism. (1972) (32)
- Cerebrospinal fluid infusion test (1974) (31)
- Computerized cranial tomography and radionuclide imaging in the detection of intracranial mass lesions. (1977) (31)
- Highly iodinated fibrinogen: a new thrombus-localizing agent. (1975) (31)
- Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. (2005) (30)
- Computed tomography and 67Ga citrate radionuclide imaging for evaluating suspected abdominal abscess. (1979) (30)
- The single palpable thyroid nodule. Evaluation by 99mTc‐pertechnetate imaging (1976) (29)
- 64 Cu-MM-302 Positron Emission Tomography Quanti fi es Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer (2017) (29)
- Detection of accessory spleens with indium 111‐labeled autologous platelets (1980) (28)
- Alzheimer's disease with abnormal cerebrospinal fluid flow (1973) (28)
- An in vivo evaluation of I-fibrinogen labeled by four different methods. (1974) (28)
- Lymphatic Drainage Patterns in Oral Squamous Cell Carcinoma (2015) (27)
- Improved interpretation of gated cardiac images by use of digital filters. (1984) (27)
- Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis. (2008) (27)
- FDG-PET lymphoma demonstration project invitational workshop. (2007) (27)
- Geographic and sociodemographic disparities in PET use by Medicare beneficiaries with cancer. (2012) (26)
- Transient alteration of the blood-brain barrier: effect of hypertonic solutions administered via carotid artery injection. (1974) (26)
- Fibrinogen uptake by thrombi: effect of thrombus age. (1975) (26)
- The use of hepatobiliary scintigraphy in patients with acalculous biliary colic. (1992) (25)
- Abstract CT234: A phase I study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+ metastatic breast cancer (2015) (25)
- PET/MRI for the body imager: abdominal and pelvic oncologic applications (2015) (24)
- Thrombus imaging with indium-111 platelets. (1983) (24)
- Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective, multicenter study (CONDOR). (2020) (23)
- Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study (2013) (23)
- Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations. (1995) (23)
- Impact of Dedicated Brain PET on Intended Patient Management in Participants of the National Oncologic PET Registry (2010) (22)
- Cost analyses of positron emission tomography for clinical use. (1983) (22)
- Role of radionuclide imaging in the evaluation of wrist pain. (1988) (22)
- Scintigraphic detection of coronary artery thrombi in patients with acute myocardial infarction. (1984) (21)
- An Imaging Comparison of 64 Cu-ATSM and 60 Cu-ATSM in Cancer of the Uterine Cervix (2008) (21)
- 18 F-Fluoroacetate : A Potential Acetate Analog for Prostate Tumor Imaging — In Vivo Evaluation of 18 F-Fluoroacetate Versus 11 C-Acetate (2007) (21)
- Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization. (1976) (21)
- Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. (2006) (21)
- Evaluation of 111 In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer (2003) (20)
- Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET. (2011) (19)
- Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy (2021) (19)
- Qualification of National Cancer Institute–Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials (2017) (18)
- Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY (2019) (18)
- Objective Task-Based Evaluation of Artificial Intelligence-Based Medical Imaging Methods:: Framework, Strategies, and Role of the Physician. (2021) (17)
- Scintigraphic detection of an arterial thrombus with In-111-labeled autologous platelets. (1980) (17)
- Gallium citrate Ga 67 accumulation in pseudomembranous colitis. (1976) (17)
- Papilledema and communicating hydrocephalus. Association with a lumbar neurofibroma. (1974) (17)
- Gated cardiac blood pool imaging and thallium-201 myocardial scintigraphy for detection of remote myocardial infarction. (1981) (16)
- Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235. (2015) (15)
- Positron tomographic imaging of the liver: 68 Ga iron hydroxide colloid. (1981) (15)
- FIAU : Human dosimetry and infection imaging in patients with suspected prosthetic joint infection (2017) (15)
- Comparison of 133Xe single-breath and washout imaging in the scintigraphic diagnosis of pulmonary embolism. (1980) (15)
- PET/CT is a cost-effective tool against cancer: synergy supersedes singularity (2016) (15)
- Splenic imaging with 99mTc-labeled erythrocytes: a comparative study of cell-damaging methods. (1976) (15)
- Procedure guideline for lung scintigraphy: 1.0. Society of Nuclear Medicine. (1996) (15)
- Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study. (2018) (15)
- FDG uptake in colonic villous adenomas (2005) (14)
- Serial lung scintigraphy: utility in diagnosis of pulmonary embolism. (1983) (14)
- Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry (2017) (14)
- Tissue distribution of 125 I-toluidine blue in the rat. (1972) (14)
- Intended Versus Inferred Treatment After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry (2017) (14)
- NCCN Task Force (2009) (14)
- A Bayesian approach to tissue-fraction estimation for oncological PET segmentation (2020) (13)
- Pathophysiologic basis of soft tissue tumor scanning (1971) (13)
- An incidental finding: a radiologist's perspective. (1993) (13)
- A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck (2014) (13)
- Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma (2019) (12)
- Adverse reactions following 3In-DTPA cisternography. (1973) (12)
- Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer (2018) (12)
- Clinical Pet Scanning: A “Short-lived” Orphan (1992) (12)
- First-in-Man Evaluation of 124I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment (2017) (12)
- Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry. (2016) (11)
- IMPACT OF AMYLOID PET ON PATIENT MANAGEMENT: EARLY RESULTS FROM THE IDEAS STUDY (2017) (11)
- Prospective Study of [ 18 F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma (2009) (11)
- Intended Versus Inferred Management After PET For Cancer Restaging: Analysis of Medicare Claims Linked to a Coverage With Evidence Development Registry (2013) (11)
- Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for 18F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease. (2020) (11)
- Imaging of canine tumors with 11C-methylputrescine. (1978) (11)
- Targeted Diagnostic Agent for Ovarian Cancer: Initial Clinical Results (2003) (11)
- FDG positron emission tomography detection of pelvic nodal metastases in gynecologic cancer. (2002) (11)
- Brain 22 Na uptake in experimental cerebral microembolism. (1973) (10)
- Observer study-based evaluation of a stochastic and physics-based method to generate oncological PET images (2021) (10)
- Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer (1994) (10)
- Radionuclide evaluation of pulmonary function following hemithorax irradiation of normal dogs with 60Co or fast neutrons. (1979) (10)
- Radionuclide imaging of dog prostate. (1978) (10)
- Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer (2021) (10)
- Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva. (2017) (10)
- Effect of Dexamethasone on Triethyl Tin Induced Brain Edema and the Early Edema in Cerebral Ischemia (1972) (10)
- Evaluation of breast and gynecologic cancers by positron emission tomography. (2002) (10)
- Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma (2017) (9)
- A new scintigraphic technique for assessment of right atrial function. (1981) (9)
- Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by 18F-FDG PET/CT: a Case Report and Review of Literature (2018) (9)
- Intended Versus Inferred Care After PET Performed for Initial Staging in the National Oncologic PET Registry (2013) (9)
- The future of positron emission tomography in clinical medicine and the impact of drug regulation. (1992) (9)
- 55PPET/CT IMAGING OF 64CU-LABELLED HER2 LIPOSOMAL DOXORUBICIN (64CU-MM-302) QUANTIFIES VARIABILITY OF LIPOSOMAL DRUG DELIVERY TO DIVERSE TUMOR LESIONS IN HER2-POSITIVE BREAST CANCER PATIENTS (2014) (8)
- Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program. (2017) (8)
- Childhood myelofibrosis and osteosclerosis without myeloid metaplasia. (1974) (8)
- Thyroid carcinoma uptake of 18F-fluorodeoxyglucose in patients with elevated serum thyroglobulin and negative 131I scintigraphy. (2013) (8)
- Imaging dementia: Evidence for amyloid scanning (IDEAS)—a national study to evaluate the clinical utility of amyloid PET (2015) (8)
- NRG-RTOG 1106/ACRIN 6697: A phase IIR trial of standard versus adaptive (mid-treatment PET-based) chemoradiotherapy for stage III NSCLC—Results and comparison to NRG-RTOG 0617 (non-personalized RT dose escalation). (2021) (8)
- Kr-81m ventilation imaging: clinical utility in suspected pulmonary embolism. (1985) (8)
- A prospective phase II/III multicenter study of PSMA-targeted 18F-DCFPyL PET/CT imaging in patients with prostate cancer (OSPREY): A sub-analysis of regional and distant metastases detection rates at initial staging by 18F-DCFPyL PET/CT. (2020) (8)
- 99mTc-pyrophosphate imaging in acute pericarditis: a clinical and experimental study. (1978) (8)
- Efficacy of skull imaging in routine bone scanning. (1974) (8)
- Measurement of intrathecal I131 ‐albumin transport to plasma (1974) (8)
- The efficacy of the brain scan in diagnosis of brainstem gliomas. (1975) (7)
- The value of liver scintigraphy in choroidal melanoma. (1979) (7)
- Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET. (2008) (7)
- Tc-99m sulfur colloid scintigraphy for detecting perigraft flow following endovascular aortic aneurysm repair: A feasibility study (1999) (7)
- Erratum: The impact of Positron Emission Tomography (PET) on expected management during cancer treatment (Cancer (2009) 115 (410-8)) (2009) (7)
- Thyroid imaging in lymphocytic throiditis. (1975) (7)
- Comparison of positron emission tomography using C-11 acetate with F-18 fluorodeoxyglucose in predicting myocardial viability (1991) (7)
- Beyond Whole-Body Imaging: Advanced Imaging Techniques of PET/MRI (2015) (7)
- Imaging techniques in the evaluation of pediatric hypertension (2004) (7)
- Guidelines for the clinical evaluation of radiopharmaceutical drugs. (1978) (7)
- Clinical Outcomes of Definitive IMRT with FDG-PET Simulation in Patients with Locally Advanced Cervical Cancer (2009) (7)
- Applications of positron emission tomography (1988) (6)
- A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR). (2019) (6)
- Radionuclide imaging in subacute sclerosing panencephalitis (1979) (6)
- Qualification of NCI-designated comprehensive cancer centers for quantitative PET/CT imaging in clinical trials (2013) (6)
- Residual Post-Treatment FDG Avidity in Regional Lymph Nodes Impacts Local-Regional Control in Patients Receiving Definitive Chemoradiation for Non-small Cell Lung Cancer: A Secondary Analysis of ACRIN 6668/RTOG 0235 (2014) (6)
- A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY). (2018) (6)
- Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response. (2021) (6)
- Medicare coverage of PET for cervical cancer. (2006) (6)
- 19 – Bone Tracers: Radionuclide Imaging and Related Techniques (1979) (6)
- Pattern Recognition Analysis of FDG-PET Uptake Characteristics for Assessing Response in NSCLC Post-radiotherapy Treatment (2008) (6)
- A proposed fluorimetric determination of unsaturated iron-binding capacity. (1975) (5)
- Radiologic Assessment of Groin Lymph Nodes in Pelvic Malignancies (2020) (5)
- Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV (2015) (5)
- Intratumoral Heterogeneity of 64Cu-ATSM Uptake is a Prognostic Indicatorin Patients with Cervical Cancer (2013) (5)
- Brain scanning and cisternography in cryptococcosis. (1973) (5)
- Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities—Phase III Studies (2019) (5)
- Dexamethasone therapy of triethyltin induced cerebral edema. (1973) (5)
- Letter from the guest editors [2] (1998) (5)
- Management of cervical nodal metastasis detected on I-131 scintigraphy after initial surgery of well-differentiated thyroid carcinoma. (2010) (4)
- External evaluation of regional cardiac lymph drainage in intact dogs. (1980) (4)
- from the National Oncologic PET Registry F-Fluoride PET in Patients with Known Prostate Cancer : Initial Results 18 Impact of (2014) (4)
- General diagnosis case of the day. Sternocostoclavicular hyperostosis. (1989) (4)
- Single palpable thyroid nodule. Evaluation by /sup 99m/Tc-pertechnetate imaging (1976) (4)
- 2014 Cassen Lecture: What have we learned from the National Oncologic PET Registry? (2014) (4)
- Recovery of contractile function in viable but dysfunctional myocardium is dependent upon maintenance of oxidative metabolism (1990) (4)
- Abstract CT070: Biomarker and clinical response of oral cavity squamous cell carcinoma to the MEK 1/2 inhibitor trametinib: A phase II neoadjuvant window of opportunity clinical trial (2016) (4)
- Scintigraphy with indium-111 platelets in cerebrovascular disease (1981) (4)
- Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose–positron emission tomography in stage IB cervical cancer (2019) (4)
- Glycerol Therapy of Experimental Cerebral Microembolism (1974) (4)
- Abstract P4-15-04: Effect of pre-treatment with cyclophosphamide on MM-302 (HER2-targeted liposomal doxorubicin) deposition in HER2-positive metastatic breast cancer patients assessed by64Cu-MM-302 PET/CT (2015) (3)
- Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 (2014) (3)
- Abstract of papers to be presented at the 39th Annual Scientific Session of the American College of Cardiology, New Orleans, Louisiana, March 18–22, 1990Regional variation in myocardial accumulation of 18F-fluorodeoxyglucose in fasted normal subjects (1990) (3)
- WITH FLUORODEOXYGLUCOSE – POSITRON EMISSION TOMOGRAPHY SIMULATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER (3)
- Abstract 5443: A phase 1 evaluation of64Cu-DOTA-patritumab to assess dosimetry, receptor occupancy, and safety in advanced solid tumors (2014) (3)
- Ventilation imaging with Kr-81m (2004) (3)
- The Chemical and Biological Properties of Isolated Radiolabeled Bleomycin Components (1975) (3)
- Cisternographic imaging patterns: effects of partial extra-arachnoid radiopharmaceutical injection and postinjection CSF leakage. (1975) (3)
- 2038 11C-ACETATE PET/CT BEFORE RADICAL PROSTATECTOMY: NODAL STAGING AND TREATMENT FAILURE PREDICTION (2012) (3)
- MP36-18 LOCALIZATION OF RECURRENCE OF PROSTATE CANCER WITH 18F-FLUCICLOVINE POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH AND WITHOUT PRIOR PROSTATECTOMY: RESULTS FROM LOCATE (2019) (2)
- Diagnostic performance of 18F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC). (2019) (2)
- Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study: A Coverage with Evidence Development Longitudinal Cohort Study (2015) (2)
- A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging. (2021) (2)
- Posterior fossa infarction: results of brain scanning. (1974) (2)
- Radionuclide studies of pulmonary function. Anatomic and physiologic considerations. (1973) (2)
- Technetium-99m diphosphonate uptake in skeletal muscle: a quantitative index of acute damage. Scientific report (1975) (2)
- Frequency and prognostic significance of clinically occult supraclavicular lymph node metastases in cervical cancer patients identified by FDG-PET (2002) (2)
- MO-DE-207B-11: Reliability of PET/CT Radiomics Features in Functional and Morphological Components of NSCLC Lesions: A Repeatability Analysis in a Prospective Multicenter Cohort. (2016) (2)
- Positron emission tomography for subsequent treatment strategy in oncology. (2014) (2)
- Radiopharmaceuticals and FDA: a clinician's perspective. (1981) (2)
- An estimation-based segmentation method to delineate tumors in PET images. (2020) (2)
- Serendipitous diagnosis of hyperthyroidism on pulmonary perfusion scintigraphy. (2011) (2)
- Positron Tomographic Imaging Of The Liver With Ga-68 Iron Hydroxide Colloid (1980) (2)
- Procedure Guideline for Somatostatin Receptor (2001) (1)
- Using 18F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA Levels. (2021) (1)
- PD60-12 SITES OF PROSTATE CANCER RECURRENCE DELINEATED WITH 18F-FLUCICLOVINE POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH NEGATIVE OR EQUIVOCAL CONVENTIONAL IMAGING (2019) (1)
- An international validation study of the prognostic role of interim FDG PET/CT in diffuse large B-cell lymphoma (2012) (1)
- 1041 : FDG-PET Definition of Gross Tumor Volume for Radiotherapy of Non-Small-Cell Lung Cancer: Is a Single SUV Threshold Approach Appropriate? (2006) (1)
- PD38-05 CLINICAL UTILITY OF PREOPERATIVE PSMA-TARGETED 18 F-DCFPYL PET/CT IN MEN WITH HIGH-RISK PROSTATE CANCER: DIAGNOSTIC PERFORMANCE COMPARISONS WITH PELVIC CT OR MRI IN THE OSPREY PROSPECTIVE, MULTI-CENTER TRIAL (2020) (1)
- Use of imaging for the diagnosis of pulmonary embolism. (2001) (1)
- Simultaneous PET/MRI acquisition: Clinical potential in anatomically focused and whole-body examinations (2013) (1)
- Attempts to augment pancreatic selenomethionine uptake: effect of raw soybean diet. (1968) (1)
- Adrenal Histoplasmosis. (2018) (1)
- OA02.04 Randomized Phase Ⅱ Trial (RTOG1106) on Midtreatment PET/CT Guided Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (2021) (1)
- Splenic imaging with /sup 99m/Tc-labeled erythrocytes: a comparative study of cell-damaging methods. [Rats, rabbits, Sn ions, sulfhydryl inhibitors] (1976) (1)
- 2203 UTILITY OF FDG-PET/CT IN IDENTIFYING BONE METASTASIS IN PATIENTS WITH BLADDER CANCER (2013) (1)
- Effect of contrast medium on amino acid transport in the brain. (1972) (1)
- Assessment of 21 8 F ] Fluoro-1 • 6 a-Ethyl-19-Norprogesterone a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas (2008) (1)
- The role of FDG-PET in advanced primary and recurrent colorectal cancer. (1996) (1)
- An estimation-based method to segment PET images (2020) (1)
- Analysis of post-irradiation FDG uptake and subsequent sites of failure for carcinoma of the cervix (2003) (1)
- Metabolic Tumor Volume Predicts Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated on ACRIN 6668/RTOG 0235 (2014) (1)
- Cervical Tumor Volume Doubling Time: A Pilot Study (2015) (1)
- 60Cu-ATSM in Cancer of the Uterine Cervix (2008) (1)
- Oncologic imaging of tumor hypoxia by Cu-ATSM and correlating findings on Cu-ATSM PET scans to cellular markers that may predict for radiation response (2004) (1)
- Can Tumor FDG-PET Scan Uptake (SUV) Predict Local Control in Stage III NSCLC? Preliminary Results from ACRIN 6668/RTOG 0235 (2011) (1)
- PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) withbiochemically recurrent prostate cancer (PCa): A phase 3 study (CONDOR)—A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth. (2021) (1)
- An exploratory pharmacogenomic study of neoadjuvant cetuximab (C225, ERBITUX®) followed by cisplatin, radiotherapy, and cetuximab in women with untreated advanced cervical cancer (2007) (1)
- Evaluation of ischemic necrosis by scintigraphy and magnetic resonance imaging (1984) (1)
- Interpretation of indeterminate lung scintigrams. [/sup 99m/Tc, /sup 133/Xe] (1979) (1)
- A prospective phase 2/3 study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging. (0)
- The role of FDG-PET in the evaluation of solitary pulmonary nodules (2008) (0)
- FDG-PET evaluation of tumor control after radiotherapy for carcinoma of the uterine cervix (1999) (0)
- Diagnostic Performance and Safety of 18F-rhPSMA-7.3 PET in Men with Suspected Prostate Cancer Recurrence: Results from a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). (2023) (0)
- Reply by Authors. (2021) (0)
- NIMG-109. A PILOT STUDY OF LYMPHOSCINTIGRAPHY WITH TRACER INJECTION IN THE HUMAN BRAIN (2022) (0)
- Pelvic Lymph Node FDG Uptake as a Prognostic Biomarker in Newly Diagnosed Locally-advanced Cervical Cancer (2009) (0)
- Prognostic Significance of Metabolic Tumor Volume After Induction Chemotherapy in Squamous Cell Carcinoma of the Head and Neck (2014) (0)
- F-FDG PET / CT in Post-therapy Monitoring of Cervical Cancer (2019) (0)
- Comparison of In-ill-Labeled Platelets and lodinated Fibrinogen for the Detection of Deep Vein Thrombosis (2006) (0)
- From: Data Management (2005) (0)
- Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography. (2022) (0)
- Kinetics and dosimetry of 124I-PGN650, a PET tracer for phosphatidylserine exposure in solid tumors. (2015) (0)
- Nuclear medicine. (1997) (0)
- Lymphatic Mapping Patterns in Early Oral Squamous Cell Carcinoma (2013) (0)
- 18F-FDG PET in Myocardial Viability Assessment: A Practical and Time-Efficient Protocol (2021) (0)
- Minoxidil and Cardiac Lesions (2005) (0)
- 18F-Fluciclovine PET/CT in patients with biochemical recurrence of prostate cancer: Impact on management and associations of clinical variables with scan findings (2018) (0)
- 11C-Acetate-PETを用いた前立腺癌再発診断 (2002) (0)
- Local versus central review of SUVpeak for stage III NSCLC (2009) (0)
- Piflufolastat F 18-PET/CT in patients with prostate cancer: An analysis of OSPREY (cohorts A and B) standardized uptake value (SUV) results stratified by PSA and Gleason score. (2022) (0)
- PD60-10 A PROSPECTIVE PHASE 2/3 MULTI-CENTER STUDY OF 18F-DCFPYL PET/CT IMAGING IN PATIENTS WITH PROSTATE CANCER – EXAMINATION OF DIAGNOSTIC ACCURACY (OSPREY) (2019) (0)
- Estrogen-Receptor Imaging and Assessing Response to Hormonal Therapy of Breast Cancer (2007) (0)
- V!z:)Ie Myocardium by Positron Emission Tomography (2016) (0)
- Prognostic value of positron emission tomography in resected stage I non-small cell lung cancer: A2-05 (2007) (0)
- An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer (2022) (0)
- 222: In Vitro and in Vivo Evaluation of 18F-Fluoroacetate: A Potential Acetate Analog for Tumor Imaging (2005) (0)
- 00003 Volumetric assessment of cervical cancer tumor volume during definitive chemoradiation and the risk of early distant metastasis (2021) (0)
- A pilot study of lymphoscintigraphy with tracer injection into the human brain. (2023) (0)
- Anal Cancer FDG Uptake is a Biomarker of Prognosis (2008) (0)
- A Manifestation of Occult RlghtVentricular Infarction (2017) (0)
- Changes in planned disease management after piflufolastat F18 PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study. (2023) (0)
- Effect of body weight on standardized uptake values on 18F-DCFPyL (PSMA) PET/CT in patients with prostate cancer. (2023) (0)
- Daniel R. Biello, M.D (1986) (0)
- Glycerol Therapy of Experimental Cerebral (2005) (0)
- Piflufolastat F 18-PET/CT in prostate cancer patients: An analysis of OSPREY (Cohorts A and B) standardized uptake value (SUV) results stratified by PSA and gleason score. (2022) (0)
- Development of an advanced PET image analysis laboratory for the American College of Radiology Imaging Network (2012) (0)
- Drs. Biello et al. reply (1980) (0)
- Localization of 99m sub T c Diphosphonate in Acutely Injured Muscle: Relationship to Muscle Calcium Deposition. (1976) (0)
- Sarcoidosis Mimicking Primary Pulmonary Artery Sarcoma. (2020) (0)
- A no-gold-standard technique to objectively evaluate quantitative imaging methods using patient data: Theory (2020) (0)
- FDG uptake as a predictor of outcome in stage I non-small cell lung cancer. (2006) (0)
- Tom R. Miller, MD, PhD (2007) (0)
- Utility of pre- and post-treatment total body I-131 scans in patients with thyroid carcinoma (1993) (0)
- /sup 111/In platelet scintigraphy in cerebrovascular disease (1982) (0)
- Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of cetuximab in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC). (2010) (0)
- Scintigraphic diagnosis of experimental pulmonary embolism with /sup 111/In-labeled platelets. [/sup 99m/Tc, dogs] (1977) (0)
- Prognostic Significance of FDG-PET/CT Metabolic Parameters After Induction Chemotherapy in Squamous Cell Carcinoma of the Head and Neck (2016) (0)
- Comparison of Tc-99m DTPA aerosol with radioactive gas ventilation imaging in patients (pts) with suspected pulmonary embolism (PE) (1984) (0)
- USP STANDARDS FOR FLUMAZENIL C 11 INJECTION (1998) (0)
- Radionuclide evaluation of pulmonary function following hemithorax irradiation of normal dogs with /sup 60/Co or fast neutrons. [/sup 133/Xe and /sup 99m/Tc--Sn--phytate] (1979) (0)
- LBA02-12 A MULTICENTER PHASE 3 STUDY OF PSMA-TARGETED 18 F-DCFPYL PET/CT IN MEN WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER: RESULTS FROM THE CONDOR TRIAL (2020) (0)
- Gamma Camera Detection of Experimental Pulmonary Emboli After Peripheral Injection of Indium-111 Labeled Platelets (1977) (0)
- Reply to J.-S. Ryu et al and A.T. Berman et al. (2014) (0)
- Multiple Tracer Assessment of Cerebral Edema in Experimental Ischemia Brain Injury (1971) (0)
- Early Assessment of Treatment Response in Acute Myeloid Leukemia Using FLT PET/CT Imaging: A Trial of the ECOG-ACRIN Cancer Research Group (EAI141) (2020) (0)
- Thyroid scan in lymphocytic thyroiditis (1974) (0)
- Regional kinetics of 111In-DTPA in CSF imaging of normal volunteers (1977) (0)
- 11C-ACETATE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY FOR PRE-OPERATIVE LYMPH NODE STAGING IN PROSTATE CANCER (2009) (0)
- MP11-11 CHANGES TO INITIAL RISK ASSESSMENT AND INTENDED PATIENT MANAGEMENT IN HIGH-RISK PROSTATE CANCER: AN EXPLORATORY ANALYSIS OF COHORT A FROM THE OSPREY TRIAL (2021) (0)
- Stress myocardial perfusion imaging (1997) (0)
- PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) with biochemically recurrent prostate cancer (PCa): A phase III study (CONDOR)—A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth. (2021) (0)
- Molecular markers associated with poor prognosis in hypoxic tumors of uterine cervix (2002) (0)
- Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma (2021) (0)
- Changes in FDG Uptake in Cervical Cancer during Treatment (2010) (0)
- A Nomogram Predicting Early Cervical Cancer Distant Recurrence. (2021) (0)
- Localization of /sup 99m/Tc diphosphonate in acutely injured muscle: relationship to muscle calcium deposition. Scientific report (1976) (0)
- In memoriam: Tom R. Miller, MD, PhD. (2007) (0)
- Response to the Letter to the Editor Regarding the Manuscript Entitled “Positron Emission Tomography with [18F]-3′-Deoxy-3′Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study” (2013) (0)
- ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate (IM) for primary and recurrent operable malignant GIST: Imaging findings and correlation with genotype and GLUT4 expression. (2016) (0)
- New NRC patient release guidelines: major quality of life & cost-containment benefits. (1998) (0)
- Washington University in St. Louis Radiation Safety Committee Membership Member Organization Department/Division (2016) (0)
- Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 : Locally Advanced Non-Small Cell Lung Cancer (2014) (0)
- 11 PET and PET/CT Imaging in Esophageal and Gastric Cancers (2017) (0)
- PET-CT as a Predictor of Regional Nodal Involvement in Head and Neck Squamous Cell Carcinomas by Disease Subsite (2019) (0)
- People in nuclear medicine: an interview with Barry A Siegel. (1993) (0)
- Translational Science and Policy and Health Outcomes (2021) (0)
- Changes in Cervical Cancer FDG Uptake Heterogeneity After Chemoradiation: Association With Tumor Recurrence and Survival (2016) (0)
- Daniel R. Biello, MD 1947–1986 (1986) (0)
- Fdg-pet in anal cancer: Impact on staging and radiotherapeutic management (2004) (0)
- Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study (2018) (0)
- 39607 Mapping the Draining Lymph Nodes in Central Nervous System Malignancies (2021) (0)
- PET and PET/CT Imaging in Esophageal and Gastric Cancers (2006) (0)
- ADVERSE REACTIONS FOLLOWING ‘11ln-DTPA CISTERNOGRAPHY (2006) (0)
- A PROSPECTIVE STUDY OF FDG-PET/CT FOR DETECTING OCCULT METASTATIC BLADDER CARCINOMA (2009) (0)
- 2335 : The Use of PET to Demonstrate Bone Marrow Preservation With IMRT (2006) (0)
- Positron emission tomography in colorectal cancer (2002) (0)
- Correlation and Prognostic Significance of Pre-treatment 18F-FDG and 64Cu-ATSM PET/CT for Cervical Cancer (2017) (0)
- Invited editorial (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Barry Alan Siegel?
Barry Alan Siegel is affiliated with the following schools:
